Janus Henderson Group PLC Acumen Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$3.91 - $6.73 $2.45 Million - $4.22 Million
-627,263 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$6.54 - $15.31 $1.52 Million - $3.57 Million
-232,918 Reduced 27.08%
627,263 $4.24 Million
Q3 2021

Nov 16, 2021
BUY
$14.5 - $20.28 $12.5 Million - $17.4 Million
860,181 New
860,181 $12.8 Million

Others Institutions Holding ABOS

# of Institutions
78
Shares Held
41.8M
Call Options Held
57.7K
Put Options Held
749K
View Full List

About Acumen Pharmaceuticals, Inc.

ABOS Quotes by TradingView
  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $96M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email